These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


840 related items for PubMed ID: 16600306

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N.
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM, Moran AP.
    J Endotoxin Res; 2000 Aug; 6(5):341-59. PubMed ID: 11521055
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N.
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [Abstract] [Full Text] [Related]

  • 9. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
    Koga M, Gilbert M, Takahashi M, Li J, Koike S, Hirata K, Yuki N.
    J Infect Dis; 2006 Feb 15; 193(4):547-55. PubMed ID: 16425134
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N.
    J Peripher Nerv Syst; 1998 Feb 15; 3(1):3-18. PubMed ID: 10959233
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG, Jacobs BC, Hazenberg MP, Bänffer JR, van der Meché FG.
    Ann Neurol; 1995 Aug 15; 38(2):170-5. PubMed ID: 7654064
    [Abstract] [Full Text] [Related]

  • 14. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
    Houliston RS, Yuki N, Hirama T, Khieu NH, Brisson JR, Gilbert M, Jarrell HC.
    Biochemistry; 2007 Jan 09; 46(1):36-44. PubMed ID: 17198373
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
    Moran AP, Annuk H, Prendergast MM.
    J Neuroimmunol; 2005 Aug 09; 165(1-2):179-85. PubMed ID: 15993494
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ganglioside mimicry and peripheral nerve disease.
    Yuki N.
    Muscle Nerve; 2007 Jun 09; 35(6):691-711. PubMed ID: 17373701
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.
    Koga M, Gilbert M, Li J, Yuki N.
    PLoS One; 2015 Jun 09; 10(4):e0124004. PubMed ID: 25867522
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 42.